Social Innovation For Health Research: Development of the SIFHR Checklist.


Journal

PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360

Informations de publication

Date de publication:
09 2021
Historique:
revised: 27 09 2021
pubmed: 14 9 2021
medline: 1 12 2021
entrez: 13 9 2021
Statut: epublish

Résumé

Social innovations in health are inclusive solutions to address the healthcare delivery gap that meet the needs of end users through a multi-stakeholder, community-engaged process. While social innovations for health have shown promise in closing the healthcare delivery gap, more research is needed to evaluate, scale up, and sustain social innovation. Research checklists can standardize and improve reporting of research findings, promote transparency, and increase replicability of study results and findings. The research checklist was developed through a 3-step community-engaged process, including a global open call for ideas, a scoping review, and a 3-round modified Delphi process. The call for entries solicited checklists and related items and was open between November 27, 2019 and February 1, 2020. In addition to the open call submissions and scoping review findings, a 17-item Social Innovation For Health Research (SIFHR) Checklist was developed based on the Template for Intervention Description and Replication (TIDieR) Checklist. The checklist was then refined during 3 rounds of Delphi surveys conducted between May and June 2020. The resulting checklist will facilitate more complete and transparent reporting, increase end-user engagement, and help assess social innovation projects. A limitation of the open call was requiring internet access, which likely discouraged participation of some subgroups. The SIFHR Checklist will strengthen the reporting of social innovation for health research studies. More research is needed on social innovation for health.

Sections du résumé

BACKGROUND
Social innovations in health are inclusive solutions to address the healthcare delivery gap that meet the needs of end users through a multi-stakeholder, community-engaged process. While social innovations for health have shown promise in closing the healthcare delivery gap, more research is needed to evaluate, scale up, and sustain social innovation. Research checklists can standardize and improve reporting of research findings, promote transparency, and increase replicability of study results and findings.
METHODS AND FINDINGS
The research checklist was developed through a 3-step community-engaged process, including a global open call for ideas, a scoping review, and a 3-round modified Delphi process. The call for entries solicited checklists and related items and was open between November 27, 2019 and February 1, 2020. In addition to the open call submissions and scoping review findings, a 17-item Social Innovation For Health Research (SIFHR) Checklist was developed based on the Template for Intervention Description and Replication (TIDieR) Checklist. The checklist was then refined during 3 rounds of Delphi surveys conducted between May and June 2020. The resulting checklist will facilitate more complete and transparent reporting, increase end-user engagement, and help assess social innovation projects. A limitation of the open call was requiring internet access, which likely discouraged participation of some subgroups.
CONCLUSIONS
The SIFHR Checklist will strengthen the reporting of social innovation for health research studies. More research is needed on social innovation for health.

Identifiants

pubmed: 34516565
doi: 10.1371/journal.pmed.1003788
pii: PMEDICINE-D-21-01155
pmc: PMC8475987
doi:

Types de publication

Guideline Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1003788

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Commentaires et corrections

Type : UpdateOf

Déclaration de conflit d'intérêts

I have read the journal’s policy and the authors of this manuscript have the following competing interests: LGC is Senior Advisor on Research for Health at the Pan American Health Organization and has contributed to SIHI Global and the SIHI-LAC (Americas) coordination. Contributions to this article do not necessarily reflect the policies or positions of his employer.

Références

J R Soc Med. 2016 Feb;109(2):67-77
pubmed: 26880653
Infect Dis Poverty. 2020 Apr 14;9(1):25
pubmed: 32284071
Infect Dis Poverty. 2020 Apr 16;9(1):36
pubmed: 32295648
BMJ Open. 2020 Apr 8;10(4):e033516
pubmed: 32273313
Lancet Glob Health. 2020 May;8(5):e633-e634
pubmed: 32353305
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Syst Rev. 2020 Feb 1;9(1):21
pubmed: 32007104
Ann Intern Med. 2012 Apr 3;156(7):525-31
pubmed: 22473437
BMC Med Res Methodol. 2019 Dec 28;19(1):243
pubmed: 31883517
BMJ Glob Health. 2020 Feb 16;5(2):e002248
pubmed: 32133198
Acad Med. 2014 Sep;89(9):1245-51
pubmed: 24979285
CMAJ. 2014 Feb 18;186(3):E123-42
pubmed: 24344144
Lancet. 2014 Jan 18;383(9913):267-76
pubmed: 24411647
Lancet Infect Dis. 2020 Aug;20(8):976-982
pubmed: 32530426
PLoS Med. 2018 Aug 28;15(8):e1002645
pubmed: 30153265
Rev Panam Salud Publica. 2020 Aug 06;44:e77
pubmed: 32774348
BMC Infect Dis. 2017 Nov 1;17(Suppl 1):701
pubmed: 29143673
Am J Trop Med Hyg. 2020 Sep;103(3):1270-1273
pubmed: 32700667

Auteurs

Eneyi E Kpokiri (EE)

Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Elizabeth Chen (E)

Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, United States of America.

Jingjing Li (J)

Social Entrepreneurship to Spur Health (SESH), Global Health Center Office, Guangzhou City, Guangdong Province, Guangzhou, China.

Sarah Payne (S)

Department of Medical Anthropology, School of Global Health, University of North Carolina, Chapel Hill, North Carolina, United States of America.

Priyanka Shrestha (P)

International Diagnostics Centre, Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Kaosar Afsana (K)

BRAC James P Grant School of Public Health, BRAC University, Dhaka, Bangladesh.

Uche Amazigo (U)

Pan-African Community Initiative on Education and Health (PACIEH), Enugu, Nigeria.

Phyllis Awor (P)

Department of Community Health and Behavioral Sciences, Makerere University School of Public Health, Kampala, Uganda.

Jean-Francois de Lavison (JF)

Ahimsa Fund, Lyon, France.

Saqif Khan (S)

BRAC Health Programme, BRAC Centre, Dhaka, Bangladesh.

Jana Mier-Alpaño (J)

Social Innovation in Health Initiative (SIHI) Philippines Hub, Department of Clinical Epidemiology, College of Medicine, University of the Philippines, Philippines.

Alberto Ong (A)

Alliance for Improving Health Outcomes (AIHO), Quezon City, Philippines.

Shivani Subhedar (S)

Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California, United States of America.

Isabelle Wachmuth (I)

Service Delivery and Safety Department, Health Systems and Innovation, World Health Organization, Geneva, Switzerland.

Luis Gabriel Cuervo (LG)

Research for Health, Pan American Health Organization, Washington, DC, United States of America.

Kala M Mehta (KM)

Institute for Global Health Sciences, University of California, San Francisco, San Francisco, California, United States of America.

Beatrice Halpaap (B)

TDR, the Special Programme for Research and Training in Tropical Diseases, cosponsored by UNICEF, UNDP, the World Bank, and WHO, Geneva, Switzerland.

Joseph D Tucker (JD)

Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Social Entrepreneurship to Spur Health (SESH), Global Health Center Office, Guangzhou City, Guangdong Province, Guangzhou, China.
Institute of Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH